Back to search

Cost-effectiveness analysis of lipid-modifying therapy in Canada: comparison of HMG-CoA reductase inhibitors in the primary prevention of coronary heart disease.

Léon L. Martens, Romain Guibert
PubMed

Data up to Jan 2025

Published1994
Citations53
References0
Fields
MedicineChemistryInternal medicinePharmacologyBiochemistry

Total Citations Per Year

Abstract

References (0)

No references found

Cited By (0)

Loading...
Cost-effectiveness analysis of lipid-modifying therapy in Canada: comparison of HMG-CoA… (1994) – PubMed | Metascience Observatory Explorer